By Roland Sebestyén
The team at Canex is delighted to announce that CBPM Access has been named as the ‘Medical Cannabis Dispensary of the Year’ in 2020. The Sunderland-based pharmacy’s dedication to the development of full-spectrum cannabis-based medicines could change the landscape in the UK.
CBPM Access, which is an acronym for cannabis-based products for medicinal use is an online pharmacy – part of EMMAC Life Sciences group, CBPM offers affordable price and ensures continuous treatment for its patients.
Essentially, CBPM Access aims to operate as a one-stop-shop, dispensing both UK manufactured and imported medical cannabis of the highest quality on a secure next day delivery service with no added dispensary fees.
According to the team, they work with “the best specialist clinics and prescribers in the UK as a trusted dispensary, to ensure they can reach as many patients as they can with treatment.”
In a short space of time, their reputation has grown substantially, priding themselves on a high level of customer service and ensuring patient needs are at the heart of everything they do.
CBPM Access is working with pharmacists, healthcare professionals and data scientists that are on-site to provide clinical expertise when needed.
In 2021, CBPM Access is looking to expand the UK manufactured range of medical cannabis offered to patients across the UK, delivering even more affordability and access.
With the aim of growing the number of patients using medical cannabis, “CBPM Access ae planning to invest and develop efficiencies that will serve to continue improving the service that the patient will receive.”
When talking about receiving the Canex Award, Paul Dunn, Superintendent Pharmacist for CBPM Access, told us: “It’s great to be recognised by this award. It reflects all the hard work our team do to navigate the complex regulatory challenges to ensure patient access to this treatment option is as simple as possible.”
For more information about Canex Award-winner CBPM Access, please click here.